Comparative potency
Xydalba has a similar spectrum of in vitro activity to the other glycopeptides, but it is more potent than vancomycin or teicoplanin15.
dalbavancin in vitro activity against S. aureus16
MRSA (N=19,721)
MRSA = Methicillin-resistant Staphylococcus aureus
MSSA (N=27,052)
MSSA = Methicillin-susceptible Staphylococcus aureus
dalbavancin in vitro activity vs. older glycopeptides against S. aureus17